Table 3.
Multivariable adjusted and corresponding univariate analyses for two major posttreatment outcomes. Transplant‐free survival and biochemical remission were assessed using multivariate Fine‐Gray subdistributional hazards model
Univariate Fine‐Gray subdistributional hazards ratio (95%CI) | P‐value | Multivariate Fine‐Gray subdistributional hazards ratio (95%CI) | P‐value | |
---|---|---|---|---|
Transplant‐free survival | ||||
Biochemical remission | 0.112 (0.0165–0.765) | 0.026 | 0.295 (0.0313–2.78) | 0.29 |
MELD score | 1.17 (1.1–1.25) | 0.001 | 1.153 (1.07–1.24) | 0.001 |
Infection | 4.24 (1.82–9.83) | 0.001 | 2.222 (0.892–5.54) | 0.086 |
Ascites grade 2/3 | 4.37 (2.0–9.56) | 0.001 | 2.556 (1.565–5.65) | 0.020 |
Biochemical remission | ||||
Serum albumin | 2.84 (1.57–5.13) | 0.001 | 2.699 (1.145–6.359) | 0.023 |
MELD score | 0.923 (0.864–0.987) | 0.019 | 1.002 (0.9214–1.09) | 0.96 |
Ascites grade 2/3 | 1.86 (0.926–3.75) | 0.081 | 0.684 (0.299–1.561) | 0.37 |
Infection | 0.090 (0.011–0.686) | 0.022 | 0.107 (0.012–0.916) | 0.041 |
MELD, model for end‐stage liver disease.